Host Bethany Brookshire leads a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg.

Quick Read

Emily Cochrane writes, “He was an Eagle Scout who had passed calculus and spoke some Mandarin. I was determined to meet him.”

Quick Read

But they’re learning hard lessons along the way. The numbers are encouraging, but only a start, educators say

Quick Read

Inhumane or Unavoidable?

June 17, 2019

As Congress scrutinizes an increase in monkey research, scientists defend its necessity

Quick Read

“We can’t stop progress with words on paper,” Denis Rebrikov said, when asked about international efforts to ban such research. Rebrikov spoke about his plans, addressing the scientific arguments against his CCR5 target and specifics about his ultimate aims and the prospect of his controversial experiment moving forward

Quick Read

Backers of Maryland’s stem cell ecosystem hope a federal judge’s ruling last week in a Florida case that the Food and Drug Administration can regulate stem cell treatments is the first step toward protecting their legitimacy. With comments from our Debra Mathews

Quick Read

The agency said two patients received donated stool that had not been screened for drug-resistant germs, leading it to halt clinical trials until researchers prove proper testing procedures are in place

Quick Read

An injured bioethicist learned firsthand how desperately patients with severe pain need the relief of powerful drugs—and how little support they get to stop taking them. Our Travis Rieder shares an essay adapted from his forthcoming book ‘In Pain: A Bioethicist’s Personal Struggle with Opioids’

Quick Read